Epsolay
Product Images NDC 0299-5890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Epsolay (NDC 0299-5890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galderma Laboratories, L.p., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30g_carton_image (Pages From 083964 P201085 0 Epsolay 30g Carton)

FDA Label Image

Chemical Structure (Epsolay 01)

FDA Label Image

Figure 1 (Figure 1)

FDA Label Image

Figure 2 (Figure 2)

FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
The text appears to be a graph showing the mean change in inflammatory lesions of a product called "Epsolay" compared to a vehicle cream over a 12-week period. Unfortunately, without the visual element of the graph, it is not possible to give a more detailed description of the data.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
The text appears to be a table or graph displaying the mean change in inflammatory lesions over a period of 12 weeks, comparing a vehicle cream to another treatment. However, without further context or clearer formatting, it is difficult to provide a more detailed description.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.